Live Chat Software
26 - 28 March, 2018
Philadelphia, PA

Media Center

2018 Pharma Anti-Counterfeiting Agenda

The 7th Annual Anti-Counterfeiting for Pharmaceuticals Summit takes a comprehensive approach to understand the latest regulations for the DSCSA to remai ...

Featured Download

Anti-counterfeiting for Pharma Registration Form

We are taking early registrations for this fantastic event. Simply download this form and send it back to enquiryiqpc@iqpc.com to fast track your attendance to this industry-leading event!

TWENTY-FIRST CENTURY THEFT: Brand Protection Strategies in the Digital Age

Christopher Reed, Senior Counsel, Content Protection Policy at Fox Entertainment Group, covers contributing factors to growth of counterfeiting, payment processors as red flags, cooperative ...

AmerisourceBergen: DSCSA Serialization and Pilot Programs

Matt Sample, from AmerisourceBergen, describes his experiences using DSCSA Serialization and Pilot Programs inside his organization in regards to traceability.

How Lexmark Curtailed Counterfeiting and Diversion

Is your company contemplating the best strategies to reduce the threat of counterfeiting? Learn about how Lexmark halted these threats with serialization, authentication, and a track and tra ...

Nipped in the Bud: The Largest Counterfeit Seizures Worldwide

Global counterfeiting is on the rise for a variety of industries, not just pharmaceuticals. This infographic details some of the most high-profile counterfeit goods seizures in recent years, ...

Cutting-Edge Issues in Brand & Content Protection

Justin Pierce, Partner at Venable, and Cynthia Tregillis, Senior Director, Brand Protection & Trademark Law at Western Digital, go into preventative measures for Border & Customs, th ...

Pharma Anti-Counterfeiting - SPONSORSHIP PROSPECTUS

Please complete the fields below to receive your copy of the 7th Pharma Anti-Counterfeiting & Brand Protection Summit prospectus which ...

Justify Your Trip Letter

Present your manager with this customizable letter detailing the reasons why you should attend the upcoming event and you'll be sure to receive approval.

Anticipated Attendee Snapshot

Detailed is an abbreviated list of Anti-Counterfeiting executives who attended the last iteration of the event. Will you be there to see what they experienced?

Anti-Counterfeiting in Pharmaceuticals: How Serialization Challenges Play a Part

One of the major aspects of anti-counterfeiting and brand protection for pharmaceuticals is the implementation of serialization along the supply chain. Ahead of the 7th Pharma Anti-Counterfeiting & Brand Protection summit, we examined the role that serialization challenges play on counterfeiting in ...

Pharma ACBP - Attendee Snapshot

Please complete the fields below to receive your copy of the 6th Pharma Anti-Counterfeiting & Brand Protection Summit ...

Heat Map: The Prioritization of Anti-Counterfeiting Measures in Developing Countries

Developing countries are the worst affected from counterfeit pharmaceuticals, regulatory structures are weaker and measurement and oversight is difficult. According to the World Health Organization, an estimated 1 in 10 medical products in low- and middle-income countries is substandard or falsif ...

DSCSA Update with Brian Files, Principal Consultant, Healthcare Supply Chain

Prior to the Anti-Counterfeiting in Pharma & Brand Protection Summit in March, we sat down for an interview with Brian Files to discuss the largest challenges and implications in integrating serialization into the supply chain, what 2024 and beyond will look like, how new technologies will af ...

Current Attendee Snapshot

In this current attendee snapshot, you will find the titles and companies of those who lead anti-counterfeiting efforts and who have signed up to be in attendance. Will you be joining them?

Additional Content Download

Intellectual Property In The Pharmaceutical Industry: Ligia Garta

Legal IQ spoke to Ligia Gata, IP Manager at Bioingenium, to discover the IP challenges faced by the Pharmaceutical industry in 2015. In this interview, Ligia provides insight on the importance of IP for R&D centers and SMEs, the key elements to consider for effectively preserving intellectual property, cutting costs using...

Pharma Counterfeiting: A $75 Billion Problem

Peggy Chaudhry is one of the leading experts on pharmaceutical anti-counterfeiting and gray markets. An economist, Professor of International Business at Villanova, and author of “Protecting Your Intellectual Property Rights,” Peggy is at the forefront of this costly and dangerous problem.

Handheld Analyzers for the Screening of Counterfeit Pharmaceuticals

Counterfeit and substandard medicines have serious human health and economic costs the magnitude of the counterfeit and substandard drug problem has gained significant public attention due to a number of high profile incidents and greater media focus. According to the Centers for Disease Control and Prevention (CDC), an estimated 10%...

Counterfeit or Not? Use a Spectrometer to Find Out

What’s the most invaluable tool you’ll need to detect counterfeit pharmaceuticals at a crime scene? Spectrometers, of course.Analytical technologies – especially portable spectrometers – play a large role in detecting counterfeit products. One of the top spectrometer experts is Ravi Kalyanaraman, an Associate Director at Bristol Myers Squibb.

Highlighting the Role of Carrier Management in Supply Chain Security

Jason Blumenauer is the Director of Global Security at Cardinal Health and an expert in supply chain security. In this interview, he discusses the role of carrier management; how he sources and selects the right carriers, assessing opportunities for theft, tips for proactively protecting against theft and, finally, appropriately responding...

Addressing Complicity to Obtain Fake Pharmaceuticals

Dr. Peggy E. Chaudry, of Villanova School of Business at Villanova University, discusses the top five harmful commodities seized, the pharmaceutical crime incidents, illegal internet pharmacies and the proposed new sentencing guidelines to handle them in this past presentation.

Curbing Diversion and Counterfeits from Entering the Supply Chain

Bruce L. Gundy is responsible for directing investigations involving crimes against AmerisourceBergen Corporation. In this past presentation, he discusses curbing diversion and counterfeits entering the supply chain, the five phases of investigation and lessons learned in the investigations.

Counterfeit Drug Detection Using Portable Spectrometer

Near-Infrared (NIR) and Raman spectral techniques, which are complimentary in nature, have been used widely to detect counterfeit drugs. Both techniques are rapid, onintrusive and nondestructive that can be used for the analysis of many classes of pharmaceutical dosage forms.This whitepaper is co-authored by speaker Ravi Kalyanaraman of Bristol-Myers Squibb.

Illegal Online Pharmacies: A Potentially Fatal Threat

Marjorie Clifton is executive director of the Center for Safe Internet Pharmacies and has over 16 years of communications, advocacy and public policy experience. She regularly appears on CNN, CNBC, Fox, and national radio.

Portable Raman Spectroscopy for Pharmaceutical Counterfeit Detection

One of the effective ways to authenticate a pharmaceutical product is by using Raman spectroscopy to obtain a unique spectral ‘fingerprint’ of the authentic drug product itself that can be used to evaluate a suspect sample by spectral comparison to determine if it is indeed a counterfeit. This whitepaper is...

Fighting Counterfeit Pharmaceuticals in Colombia

Eugene Hackett, Director, Corporate Security, Bristol-Myers Squibb Company, discusses the improvements in the penal law, the private/public partnership and best practices for combating counterfeits with a focus on Columbia in this past presentation.

Leveraging Serialization/E-Pedigree Mandates to Achieve Brand Protection

Steve Stein, Technical Accounts Manager at KODAK and John J. DiPalo, Chief Operating Officer at Acsis, discuss a century of regulatory change from products to packaging to pedigree in this past presentation.

Portable Spectrometers for Pharmaceutical Counterfeit Detection

Technological advancements in Micro-Electromechanical Systems (MEMS) for NIR, and in the telecommunication laser industry for Raman, along with advances in optical and detector components miniaturization for both, have led to drastic reductions in size of these spectrometers which have made them portable. This whitepaper is co-authored by speaker Ravi Kalyanaraman...

Achieving Scannable GS1 Codes for DSCSA Compliance

Counterfeit and diverted pharmaceuticals are major problems that put consumer health and company reputations at risk in the global market. As part of an effort to overhaul track and trace rules and increase the accuracy of supply chain information, the U.S. Food and Drug Administration (FDA) is implementing widespread changes...

Measuring the Magnitude of Global Counterfeiting

The continuous growth of the global counterfeiting industry is a major cause for concern. Fueled by the proliferation of internet use and social media platforms, the magnitude of global physical counterfeiting is estimated to have increased considerably since the beginning of this century. The US Chamber’s Measuring the Magnitude of...

The Next Great Serial: Pharmaceutical Security

How can the patient be sure the medication he/she is going to take is exactly what the doctor ordered? Every year, substandard, spurious, falsely-labeled, falsified and counterfeit drugs work their way into the market and eventually into the homes and hands of patients treating everything from routine illnesses to chronic...

One Approach to Serialization and Aggregation for Contract Manufacturing Organizations

Serialization/aggregation regulations are being implemented or are already in place, in many countries around the world.Contract development and manufacturing organizations (CDMOs) have their own unique set of challenges to meeting serialization requirements. Servier CDMO began tackling this problem early on, to not only be in compliance, but to be positioned...

Finding Fakes

Estimates suggest that the global counterfeit drug market sits somewhere between US$75 and $200 billion and represents 10–50 percent of all drugs sold in some low-income countries. This articles looks at the past, present, and future of counterfeiting drug screening.To request a copy >>> enquiryiqpc@iqpc.com 

Raman Spectral Fingerprinting For Biologics Counterfeit Drug Detection

This article demonstrates that Drop Coat Deposition (DCD) technique for the biologics drug product sample, coupled with confocal Raman spectroscopy can be effectively used to fingerprint protein based biologics pharmaceuticals. These spectral fingerprints can be used routinely to screen and detect biologics counterfeits.To receive a copy via email >>> enquiryiqpc@iqpc.com 

Counterfeit Medication - A Global Risk

As Internet activity grows, the availability of medication online has also increased. Consumers may be tricked into buying what they think is real only to pay the ultimate price when they take counterfeit medication. So, how can the pharmaceutical industry tackle this problem and keep consumers safe from harm?